NRx Pharmaceuticals Shares Are Trading Lower After the Company Announced Findings From Its Phase 2b/3 Trial of NRX-101 Vs. Lurasidone
nRx Pharmicals公佈了其 NRX-101 Vs. 2b/3階段試驗的結果後,該公司股價走低盧拉西酮
NRx Pharmaceuticals Shares Are Trading Lower After the Company Announced Findings From Its Phase 2b/3 Trial of NRX-101 Vs. Lurasidone
nRx Pharmicals公佈了其 NRX-101 Vs. 2b/3階段試驗的結果後,該公司股價走低盧拉西酮
使用瀏覽器的分享功能,分享給你的好友吧